Inhibitors of serine/threonine protein phosphatases antagonize the antinociception induced by agonists of α2 adrenoceptors and GABAB but not κ-opioid receptors in the tail flick test in mice

Pain

Volumn 114, Issue 1-2, 2005, Pages 212-220

  Moncada, Ana ^a   Cendán, Cruz Miguel ^a   Baeyens, José M ^a   Del Pozo, Esperanza ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Antinociception; Cantharidin; G protein coupled receptors; Okadaic acid; Serine threonine protein phosphatases; Tail flick test

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA2 ADRENERGIC RECEPTOR AGONIST; ANALGESIC AGENT; BACLOFEN; CANTHARIDIN; CLONIDINE; KAPPA OPIATE RECEPTOR AGONIST; LEVO NOROKADAONE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOTRANSFERASE INHIBITOR; SERINE PROTEIN PHOSPHATASE; SERINE PROTEIN PHOSPHATASE INHIBITOR; THREONINE PROTEIN PHOSPHATASE; THREONINE PROTEIN PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; INHIBITION KINETICS; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

EID: 14044279092     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.12.017     Document Type: Article

References (58)

1. 1b-adrenoceptor phosphorylation: effects of okadaic acid Br J Pharmacol 129 2000 727 730
2. M.A. Ansonoff, and A.M. Etgen Receptor phosphorylation mediates estradiol reduction of alpha2-adrenoceptor coupling to G protein in the hypothalamus of female rats Endocrine 14 2001 165 174
3. 1-adrenoceptor-linked phosphoinositide metabolism in cultured glia: involvement of protein phosphatases and kinases Cell Signal 15 2003 403 412
4. M.A. Bernstein, and S.P. Welch Inhibition of protein phosphatases alters the expression of morphine tolerance in mice Eur J Pharmacol 341 1998 173 177
5. C. Bialojan, and A. Takai Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics Biochem J 256 1988 283 290
6. B receptor pharmacology Annu Rev Pharmacol Toxicol 33 1993 109 147
7. i2 Biochem J 274 1991 317 321
8. S.F. Chan, and N.J. Sucher An NMDA receptor signalling complex with protein phosphatase 2A J Neurosci 21 2001 7985 7992
9. M.X. Chen, A.E. McPartlin, L. Brown, Y.H. Chen, H.M. Barker, and P.T. Cohen A novel human protein serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus Eur Mol Biol Org J 13 1994 4278 4280
10. 2+ channel current in rat pinealocytes: role of basal phosphorylation J Neurochem 72 1999 73 80
11. P.T.W. Cohen, S. Klumpp, and D.L. Schelling An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues Fed Eur Biochem Soc Lett 250 1989 596 600
12. P. Cohen, C.F. Holmes, and Y. Tsukitani Okadaic acid: a new probe for the study of cellular regulation Trends Biochem Sci 15 1990 98 102
13. v1.2) and antagonizes channel phosphorylation by cAMP-dependent protein kinase J Biol Chem 275 2000 39710 39717
14. E. Del Pozo, C. Ruiz-Garcia, and J.M. Baeyens Analgesic effects of diltiazem and verapamil after central and peripheral administration in the hot-plate test Gen Pharmacol 21 1990 681 685
15. M. Dierssen, J. Florez, and M.A. Hurle Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions Naunyn Schmiedeberg's Arch Pharmacol 342 1990 559 565
16. A. Dogrul, O. Yesilyurt, A. Isimer, and M.E. Guzeldemir L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective μ opioid agonist, but not to selective δ and κ agonist at the level of the spinal cord in mice Pain 93 2001 61 68
17. T.A. Firth, G.M. Mawe, and M.T. Nelson Pharmacology and modulation of K(ATP) channels by protein kinase C and phosphatases in gallbladder smooth muscle Am J Physiol Cell Physiol 278 2000 C1031 C1037
18. J.D. Foster, B. Pananusorn, M.A. Cervinski, H.E. Holden, and R.A. Vaughan Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1 Brain Res Mol Brain Res 110 2003 100 108
19. oα subunits restore the efficacy of opioids, clonidine and neurotensin giving rise to antinociception in G-protein knock-down mice Neuropharmacology 38 1999 1861 1873
20. J.A. Girault Protein kinases and phosphatases Neurotransmissions 10 1994 1 6
21. T.J. Haley, and W.G. Mccormick Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse Br J Pharmacol 12 1957 12 15
22. C.J. Hastie, and P.T. Cohen Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters Fed Eur Biochem Soc Lett 431 1998 357 361
23. H.C. Hemmings, A.C. Nairn, T.L. McGuinness, R.L. Huganir, and P. Greengard Role of protein phosphorylation in neuronal signal transduction Fed Am Soc Exp Biol J 3 1989 1583 1592
24. S. Herzig, and J. Neumann Effects of serine/threonine protein phosphatases on ion channels in excitable membranes Pharmacol Rev 80 2000 173 196
25. N.D. Holliday, I.R. Tough, and H.M. Cox Inhibition of cyclic AMP-dependent chloride secretion by PP receptors and alpha 2-adrenoceptors in a human colonic epithelial cell line Naunyn-Schmiedeberg's Arch Pharmacol 355 1997 183 189
26. R.E. Honkanen Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A Fed Eur Biochem Soc Lett 330 1993 283 286
27. R.E. Honkanen, and T. Golden Regulators of serine/threonine protein phosphatases at the dawn of a clinical era? Curr Med Chem 9 2002 2055 2075
28. R.E. Honkanen, B.A. Codispoti, K. Tse, and A.L. Boynton Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases Toxicon 32 1994 339 350
29. X. Huang, and R.E. Honkanen Molecular cloning, expression, and characterization of a novel human serine/threonine protein phosphatase, PP7, that is homologous to Drosophila retinal degeneration C gene product (rdgC) J Biol Chem 273 1998 1462 1468
30. B receptors J Physiol 492 1996 115 127
31. + channels in caudal raphe neurons Neuroscience 82 1998 753 765
32. Y.M. Li, and J.E. Casida Cantharidin-binding protein: identification as protein phosphatase 2A Proc Natl Acad Sci 89 1992 11867 11870
33. 3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues Biochem Pharmacol 46 1993 1435 1443
34. P.E. Light, B.G. Allen, M.P. Walsh, and R.J. French Regulation of adenosine triphosphate-sensitive potassium channels from rabbit ventricular myocytes by protein kinase C and type 2A protein phosphatase Biochemistry 34 1995 7252 7257
35. S. Mitsuhashi, N. Matsuura, M. Ubukata, H. Oikawa, H. Shima, and K. Kikuchi Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1 Biochem Biophys Res Commun 287 2001 328 331
36. A. Moncada, C.M. Cendan, J.M. Baeyens, and E. Del Pozo Effects of serine/threonine protein phosphatase inhibitors on morphine-induced antinociception in the tail flick test in mice Eur J Pharmacol 465 2003 53 60
37. C. Mullner, D. Yakubovich, C.W. Dessauer, D. Platzer, and W. Schreibmayer Single channel analysis of the regulation of GIRK1/GIRK4 channels by protein phosphorylation Biophys J 84 2003 1399 1409
38. S. Nishiwaki, H. Fujiti, M. Suganuma, H. Furuya-Suguri, R. Matsushima, Y. Iida, M. Ojika, K. Yamada, D. Uemura, and T. Yasumoto Structure-activity relationship within a series of okadaic acid derivatives Carcinogenesis 11 1990 1837 1841
39. B and κ-opioid receptor agonists Br J Pharmacol 110 1993 1049 1054
40. + channel blockers antagonize morphine- but not U-504,88H-induced antinociception Eur J Pharmacol 230 1993 203 207
41. + channel-acting drugs Br J Pharmacol 114 1995 1296 1302
42. B, Mu and Kappa opioid receptors J Pharmacol Exp Ther 276 1996 1136 1142
43. M. Ocaña, C.M. Cendán, E.J. Cobos, J.M. Entrena, and J.M. Baeyens Potassium channels and pain: present realities and future opportunities Eur J Pharmacol 500 2004 203 219
44. B receptor-mediated high-affinity guanosine triphosphatase activity in rat cerebral cortical membranes Neurosci Lett 297 2001 137 141
45. 2C-adrenoceptors in human neuroblastoma SH-SY5Y cells Eur J Pharmacol 372 1999 109 111
46. + channels mediates the antinociceptive effect of Crotalus durissus terrificus snake venom Eur J Pharmacol 469 2003 57 64
47. N.E. Price, and M.C. Mumby Brain protein serine/threonine phosphatases Curr Opin Neurobiol 9 1999 336 342
48. 1A receptors Eur J Pharmacol 295 1996 181 188
49. iα2 attenuates inhibitory adenylyl cyclase in neuroblastoma/glioma hybrid (NG-10815) cells J Biol Chem 269 1994 14307 14313
50. D. Strassheim, P.Y. Law, and H.H. Loh Contribution of phospholipase C-beta 3 phosphorylation to the rapid attenuation opioid-activated phosphoinositide response Mol Pharmacol 53 1998 1047 1053
51. 1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons Neuron 14 1995 385 397
52. J. Vázquez-Prado, P. Casas-González, and A. García-Sáinz G protein-coupled receptor cross-talk: pivotal roles of protein phosphorylation and protein-protein interactions Cell Signal 15 2003 549 557
53. A.H. Walsh, A. Cheng, and R.E. Honkanen Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A Fed Eur Biochem Soc Lett 416 1997 230 234
54. L. Wang, V.M. Medina, M. Rivera, and A.R. Gintzler Relevance of phosphorylation state to opioid responsiveness in opiate naive and tolerant/dependent tissue Brain Res 723 1996 61 69
55. Z.Y. Wei, and S.C. Roerig Spinal morphine/clonidine antinociceptive synergism is regulated by protein kinase C, but not protein kinase A activity J Pharmacol Exp Ther 287 1998 937 943
56. S.P. Welch, and L.D. Dunlow Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action? J Pharmacol Exp Ther 267 1993 399
57. X. Zhang, J. Wu, L. Fang, and W.D. Willis The effects of protein phosphatase inhibitors on nociceptive behavioural responses of rats following intradermal injection of capsaicin Pain 106 2003 443 451
58. M. Zimmermann Ethical guidelines for investigations of experimental pain in conscious animals Pain 16 1983 109 110